The Role of Autoantibodies in Lambert‐Eaton Myasthenic Syndromea a
1998; Wiley; Volume: 841; Issue: 1 Linguagem: Inglês
10.1111/j.1749-6632.1998.tb10992.x
ISSN1749-6632
AutoresBethan Lang, Sally A. Waterman, Ashwin Pinto, DOMINIC JONES, Fraser J. Moss, John R. Boot, Paul F. Brust, Mark E. Williams, Kenneth A. Stauderman, Michael M. Harpold, Masakatsu Motomura, J. W. Moll, Angela Vincent, John Newsom–Davis,
Tópico(s)Cellular transport and secretion
ResumoAnnals of the New York Academy of SciencesVolume 841, Issue 1 p. 596-605 The Role of Autoantibodies in Lambert-Eaton Myasthenic Syndromeaa BETHAN LANG, BETHAN LANG Neurosciences Group; Institute of Molecular Medicine; University of Oxford; Oxford OX3 9DU, United KingdomSearch for more papers by this authorSALLY WATERMAN, SALLY WATERMAN Neurosciences Group; Institute of Molecular Medicine; University of Oxford; Oxford OX3 9DU, United KingdomSearch for more papers by this authorASHWIN PINTO, ASHWIN PINTO Neurosciences Group; Institute of Molecular Medicine; University of Oxford; Oxford OX3 9DU, United KingdomSearch for more papers by this authorDOMINIC JONES, DOMINIC JONES Neurosciences Group; Institute of Molecular Medicine; University of Oxford; Oxford OX3 9DU, United KingdomSearch for more papers by this authorFRASER MOSS, FRASER MOSS Lilly Research Center Limited; Windlesham, Surrey, United KingdomSearch for more papers by this authorJOHN BOOT, JOHN BOOT Lilly Research Center Limited; Windlesham, Surrey, United KingdomSearch for more papers by this authorPAUL BRUST, PAUL BRUST SIBIA Neurosciences Incorporated; La Jolla, California 92037Search for more papers by this authorMARK WILLIAMS, MARK WILLIAMS SIBIA Neurosciences Incorporated; La Jolla, California 92037Search for more papers by this authorKENNETH STAUDERMAN, KENNETH STAUDERMAN SIBIA Neurosciences Incorporated; La Jolla, California 92037Search for more papers by this authorMICHAEL HARPOLD, MICHAEL HARPOLD SIBIA Neurosciences Incorporated; La Jolla, California 92037Search for more papers by this authorMASAKATSU MOTOMURA, MASAKATSU MOTOMURA First Department of Internal Medicine; Nagasaki University School of Medicine; Nagasaki 852, JapanSearch for more papers by this authorJ. WIBE MOLL, J. WIBE MOLL Department of Neuro-Oncology; Dr. Daniel den Hoed Cancer Center; 3075 EA Rotterdam, the NetherlandsSearch for more papers by this authorANGELA VINCENT, ANGELA VINCENT Neurosciences Group; Institute of Molecular Medicine; University of Oxford; Oxford OX3 9DU, United KingdomSearch for more papers by this authorJOHN NEWSOM-DAVIS, JOHN NEWSOM-DAVIS Neurosciences Group; Institute of Molecular Medicine; University of Oxford; Oxford OX3 9DU, United KingdomSearch for more papers by this author BETHAN LANG, BETHAN LANG Neurosciences Group; Institute of Molecular Medicine; University of Oxford; Oxford OX3 9DU, United KingdomSearch for more papers by this authorSALLY WATERMAN, SALLY WATERMAN Neurosciences Group; Institute of Molecular Medicine; University of Oxford; Oxford OX3 9DU, United KingdomSearch for more papers by this authorASHWIN PINTO, ASHWIN PINTO Neurosciences Group; Institute of Molecular Medicine; University of Oxford; Oxford OX3 9DU, United KingdomSearch for more papers by this authorDOMINIC JONES, DOMINIC JONES Neurosciences Group; Institute of Molecular Medicine; University of Oxford; Oxford OX3 9DU, United KingdomSearch for more papers by this authorFRASER MOSS, FRASER MOSS Lilly Research Center Limited; Windlesham, Surrey, United KingdomSearch for more papers by this authorJOHN BOOT, JOHN BOOT Lilly Research Center Limited; Windlesham, Surrey, United KingdomSearch for more papers by this authorPAUL BRUST, PAUL BRUST SIBIA Neurosciences Incorporated; La Jolla, California 92037Search for more papers by this authorMARK WILLIAMS, MARK WILLIAMS SIBIA Neurosciences Incorporated; La Jolla, California 92037Search for more papers by this authorKENNETH STAUDERMAN, KENNETH STAUDERMAN SIBIA Neurosciences Incorporated; La Jolla, California 92037Search for more papers by this authorMICHAEL HARPOLD, MICHAEL HARPOLD SIBIA Neurosciences Incorporated; La Jolla, California 92037Search for more papers by this authorMASAKATSU MOTOMURA, MASAKATSU MOTOMURA First Department of Internal Medicine; Nagasaki University School of Medicine; Nagasaki 852, JapanSearch for more papers by this authorJ. WIBE MOLL, J. WIBE MOLL Department of Neuro-Oncology; Dr. Daniel den Hoed Cancer Center; 3075 EA Rotterdam, the NetherlandsSearch for more papers by this authorANGELA VINCENT, ANGELA VINCENT Neurosciences Group; Institute of Molecular Medicine; University of Oxford; Oxford OX3 9DU, United KingdomSearch for more papers by this authorJOHN NEWSOM-DAVIS, JOHN NEWSOM-DAVIS Neurosciences Group; Institute of Molecular Medicine; University of Oxford; Oxford OX3 9DU, United KingdomSearch for more papers by this author First published: 07 February 2006 https://doi.org/10.1111/j.1749-6632.1998.tb10992.xCitations: 23 a This work was supported by the Medical Research Council (United Kingdom), the Myasthenia Gravis Association (United Kingdom), the Queen's Trust of Australia, the Leopold Muller Estate, the Sir Jules Thorne Charitable Trust, the Nuffield Foundation, and Jesus College, Oxford. A. Pinto is a recipient of a Wellcome Trust Research Fellowship and M. Motomura held a Wellcome Trust Research Travelling Fellowship. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume841, Issue1MYASTHENIA GRAVIS AND RELATED DISEASES: DISORDERS OF THE NEUROMUSCULAR JUNCTIONMay 1998Pages 596-605 RelatedInformation
Referência(s)